Summary In the process of tumour progression genetic instability is the basis for the evolution of tumour cell clones with various genotypic and phenotypic characteristics causing heterogeneity. Renal cell carcinoma has a long prediagnostic growth period, which increases the probability of clonal evolution. We have studied 200 consecutive renal cell carcinomas, addressing the interrelationship between intratumour heterogeneity and clinicopathological factors. DNA ploidy patterns were analysed in multiple samples from each tumour 
In tumours stepwise genetic changes occur during the course of the disease. Each step might induce the emergence of a new subclone with a selective growth advantage (Weiss, 1985; Vogelstein et al., 1989) . This evolution proceeds towards increased autonomy by a temporal change in various tumour cell characteristics, where the acquisition or loss of various phenotypes can be independent of each other (Nicholson, 1987) . It is evident that malignant tumours contain a variety of subpopulations of cells with different invasive and metastatic capabilities and that increased genetic instability enhances the rate of tumour progression (Nowell, 1986) .
In renal cell carcinoma we have previously demonstrated heterogeneity regarding DNA ploidy, karyotype, DNA fingerprint pattern and cell kinetic properties (Larsson et al., 1993; Ljungberg et al., 1985 Ljungberg et al., , 1994 Mehle et al., 1993; Nordenson et al., 1988) . The most powerful prognostic parameter in renal cell carcinoma is tumour stage but DNA ploidy and cell kinetic parameters have also been found to be of predictive value (Baretton et al., 1991; Larsson et al., 1993; Ljungberg et al., 1994; Skinner et al., 1971 ). This tumour type shows a wide spectrum regarding clinical behaviour, from cases with early metastatic presentation to tumours with considerable local growth without invasion or distant manifestations for many years (Skinner et al., 1971 . At diagnosis renal cell carcinoma has a mean diameter of approximately 8 cm, indicating a long prediagnostic tumour growth period. Therefore renal cell carcinoma provides a model for undisturbed malignant growth that can give important information regarding clonal evolution, leading to intratumour heterogeneity, and its clinical significance. Although heterogeneity is well recognised in many tumours, no data are available regarding the possible impact of this phenomenon for prognosis.
In the present study a series of 200 renal cell carcinomas was analysed concerning intratumour heterogeneity, judged by DNA ploidy analysis, and its influence on clinicopathological parameters, including outcome for the patients, was evaluated. Robson et al. (1969) . Preoperatively, the patients were examined with chest radiography, ultrasound and computerised tomography and, in patients with symptoms or signs of bone metastases, with bone scans. The perifascial nephrectomies were performed en bloc with kidney, perirenal fat and Gerota's fascia, including all tissue from the midline of the aorta in left-sided tumours and from the midline of the vena cava in right-sided tumours. In cases with enlarged or palpable lymph nodes between the aorta and the cava lymph node dissections were performed. Radical retroperitoneal lymph node dissections were not performed. The patients were followed up according to a programme including clinical and radiological examinations. In October 1994, the mean follow-up time for alive patients was 57.8 months (median 53.0, range 3-142 months).
Materials and methods

Tumours
The tumour specimens were obtained by schematically taken biopsies from the nephrectomised kidney with tumour and kidney cortex samples (Ljungberg et al., 1985) . From each tumour generally six (4-8) samples were taken, and from each sample one part was processed for flow cytometric DNA analysis and another part for conventional histopathological examination. Histopathological grade was defined according to Skinner et al. (1971) . The examination included, apart from the six (4-8) tumour samples primarily taken, microscopical evaluation of local tumour invasion using the parameter's sharp or diffuse demarcation of the tumour to adjacent kidney cortex tissue, through the renal capsule into Correspondence: B Ljungberg Received 7 September 1995; revised 2 January 1996; accepted 15 January 1996 the perirenal fat and presence of tumour invasion into major veins in the hilar region. Histopathologically diffuse or infiltrating demarcation of the tumour to adjacent tissues was judged as one feature of local invasion.
DNA analysis
The method for flow cytometric DNA analysis has been described previously (Ljungberg et al., 1985) . Briefly, the fresh samples were minced and stained using a propidium iodide solution. Table II . A majority of the homogeneously diploid tumours were in stage I (60%), in contrast to the aneuploid tumours (35%) whereas the fractions of stage IV tumours were similar (23% and 34% respectively). In the aneuploid tumours, stage I and stage IV tumours were equally distributed. Diploid tumours differed significantly from tumours bearing aneuploid clones regarding local tumour invasion properties (Table III) . However, the frequency of primary synchronous metastases was similar for all ploidy groups, while there was a significantly higher (Figure 2 ). At least four tumour samples were needed to nd 18 A/A. (c) achieve more than 90% probability of detecting aneuploidy.
,A/A. Discussion frequency of metachronous metastases in patients with aneuploid tumours (Table IV) (Mehle et al.. 1993; Nordenson et al.. 1988) . Intratumour heterogeneity regarding DNA ploidy has also been described for other tumours. such as breast cancer (Barranco et al.. 1994; Beerman et al.. 1991; Fern6 et al.. 1992) . gastrointestinal carcinoma (Hiddeman et al., 1986; Sasaki et al.. 1988 ), oesophageal squamous cell carcinoma (Sasaki et al., 1991) and bladder carcinoma (Norming et al.. 1992) . However, in the present study the clinical relevance of heterogeneity was also documented and evaluated. The renal cell carcinoma material presently studied is unique in its size and together with a thorough characterisation of clinicopathological parameters was used as a basis for analysis of the clinical impact of intratumour heterogeneity. The heterogeneity itself seemed to have no prognostic significance. The most significant result was the finding that aneuploidy within a tumour was a strong prognostic indicator, and predictive value was found even if aneuploidy was demonstrated in only one sample of a tumour. The degree of heterogeneity within aneuploid tumours did not influence the prognosis and did not predict any clinical parameter. The prognostic relevance was shown both for patients without metastases as well as for patients with distant metastases at diagnosis. Local invasive behaviour and spread was also related to the DNA ploidy level, which is in line with a report on a smaller series of tumours . There was also a difference between diploid and aneuploid tumours regarding the occurrence of distant metastases. although distant metastases at the time of diagnosis were demonstrated in almost the same frequency in both groups. Thus, it is obvious that subclones of tumour cells defined by their DNA ploidy character had different invasive and metastatic capabilities, which could explain the differences seen regarding survival.
An association between DNA ploidy and tumour cell kinetics has been reported with lower S-phase fractions and longer potential tumour doubling times (Tpo,) in diploid compared with aneuploid clones (Baretton et al.. 1991; Larsson et al., 1993; Ljungberg et al.. 1994) . In a study of in vivo labelling with iododeoxyuridine the shortest Tpot value detected within a tumour was of high prognostic significance . In the present study, tumours with aneuploidy were larger than diploid tumours. These data indicate a connection between aneuploidy. high growth rate and a tendency for local spread and progressive disease. In contrast, diploid tumour cell clones had a lower proliferation rate and metastasised later in the disease history.
It is obvious from the data presented here that multiple sampling is mandatory in order to properly evaluate the malignant potential of a renal cell carcinoma owing to the high degree of heterogeneity present. In a previous study analysing only one tumour sample. DNA ploidy of the primary tumours gave no prognostic information (Ljungberg et al.,. 1986 ). We recommend that at least four different samples should be analysed separately in each primary tumour to secure at least a 90% probability of obtaining aneuploidy. Another approach to evaluating heterogeneous tumours is to use a mixture of different samples as suggested by Barranco et al., (1994) . However, owing to dilution a small aneuploid clone could be undetected using the mixture approach. The evaluation of molecular genetic characteristics might also be improved by separate analysis of multiple samples as illustrated by DNA fingerprint patterns, telomere length fragment determinations (Mehle et al., 1993 (Mehle et al., , 1994 and analysis of polymorphic microsatellite markers (unpublished data).
In the present study heterogeneity itself. evaluated by DNA ploidy, had no prognostic significance in renal cell carcinoma. Multiple sampling is essential to reveal aneuploidy with a high probability. The presence of aneuploidy within a tumour is a main predictive parameter associated with high proliferation. local tumour invasion and poor prognosis. The more precise genetic events responsible for these tumour
features have yet to be charactenrsed.
